Pharmacia launches new blood alcohol test:
This article was originally published in Clinica
Executive Summary
Pharmacia (Sweden) has launched its radio-immunoassay CDTect for the detection and measurement of alcohol in blood. The product is on sale in Germany, France and Scandinavia. Testing for biochemical markers enables more sophisticated analysis of alcohol use and dependency than conventional breath tests, says Dr Rolf Iffland in Arzte Zeitung. However, forensic medicine relies solely on traditional methods for diagnosis. Dr Iffland argues that traditional breath tests do not detect many drivers who are shown to be over the limit of alcohol consumption using CDTect. The product is also capable of differentiating between those who have consumed large quantities of alcohol on single occasions and those who habitually drink heavily.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.